Can Genetics Tackle COVID-19 with Drug Repurposing

In COVID-19, Latest News by Precision Vaccinations

Each SARS-CoV-2 betacoronavirus infection has variable severities in people, ranging from asymptomatic to severe life-threatening respiratory failure, coagulation, or neurological symptoms, among other sequelae, said genomics researchers in a blog posting on July 7, 2021.
These individual-level responses to infection have led scientists to investigate the effects of genetic variation in the human genome that may explain the broad spectrum of COVID-19 severity and susceptibility, continues the article.

Read More